165 related articles for article (PubMed ID: 22335894)
1. New aromatase inhibitors from the 3-pyridyl arylether and 1-aryl pyrrolo[2,3-c]pyridine series.
Stauffer F; Furet P; Floersheimer A; Lang M
Bioorg Med Chem Lett; 2012 Mar; 22(5):1860-3. PubMed ID: 22335894
[TBL] [Abstract][Full Text] [Related]
2. An efficient steroid pharmacophore-based strategy to identify new aromatase inhibitors.
Neves MA; Dinis TC; Colombo G; Sá e Melo ML
Eur J Med Chem; 2009 Oct; 44(10):4121-7. PubMed ID: 19500885
[TBL] [Abstract][Full Text] [Related]
3. Pharmacophore modeling strategies for the development of novel nonsteroidal inhibitors of human aromatase (CYP19).
Muftuoglu Y; Mustata G
Bioorg Med Chem Lett; 2010 May; 20(10):3050-64. PubMed ID: 20413308
[TBL] [Abstract][Full Text] [Related]
4. Investigation of aryl halides as ketone bioisosteres: refinement of potent and selective inhibitors of human cytochrome P450 19A1 (aromatase).
McNulty J; Nielsen AJ; Brown CE; DiFrancesco BR; Vurgun N; Nair JJ; Crankshaw DJ; Holloway AC
Bioorg Med Chem Lett; 2013 Nov; 23(22):6060-3. PubMed ID: 24113062
[TBL] [Abstract][Full Text] [Related]
5. The tamoxifen metabolite norendoxifen is a potent and selective inhibitor of aromatase (CYP19) and a potential lead compound for novel therapeutic agents.
Lu WJ; Xu C; Pei Z; Mayhoub AS; Cushman M; Flockhart DA
Breast Cancer Res Treat; 2012 May; 133(1):99-109. PubMed ID: 21814747
[TBL] [Abstract][Full Text] [Related]
6. Recent developments in steroidal and nonsteroidal aromatase inhibitors for the chemoprevention of estrogen-dependent breast cancer.
Ahmad I; Shagufta
Eur J Med Chem; 2015 Sep; 102():375-86. PubMed ID: 26301554
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and aromatase inhibitory activity of novel pyridine-containing isoflavones.
Kim YW; Hackett JC; Brueggemeier RW
J Med Chem; 2004 Jul; 47(16):4032-40. PubMed ID: 15267241
[TBL] [Abstract][Full Text] [Related]
8. Pyridine-substituted thiazolylphenol derivatives: Synthesis, modeling studies, aromatase inhibition, and antiproliferative activity evaluation.
Ertas M; Sahin Z; Berk B; Yurttas L; Biltekin SN; Demirayak S
Arch Pharm (Weinheim); 2018 Apr; 351(3-4):e1700272. PubMed ID: 29522642
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and evaluation of 4-triazolylflavans as new aromatase inhibitors.
Yahiaoui S; Pouget C; Fagnere C; Champavier Y; Habrioux G; Chulia AJ
Bioorg Med Chem Lett; 2004 Oct; 14(20):5215-8. PubMed ID: 15380230
[TBL] [Abstract][Full Text] [Related]
10. Design, Synthesis, and Biological Evaluation of New Azole Derivatives as Potent Aromatase Inhibitors with Potential Effects against Breast Cancer.
Kalalinia F; Jouya M; Komachali AK; Aboutourabzadeh SM; Karimi G; Behravan J; Abnous K; Etemad L; Kamali H; Hadizadeh F
Anticancer Agents Med Chem; 2018; 18(7):1016-1024. PubMed ID: 29336269
[TBL] [Abstract][Full Text] [Related]
11. Aromatase: the enzyme and its inhibition.
Banting L; Ahmed S
Anticancer Agents Med Chem; 2009 Jul; 9(6):627-41. PubMed ID: 19601746
[TBL] [Abstract][Full Text] [Related]
12. Steroidal pyrazolines evaluated as aromatase and quinone reductase-2 inhibitors for chemoprevention of cancer.
Abdalla MM; Al-Omar MA; Bhat MA; Amr AG; Al-Mohizea AM
Int J Biol Macromol; 2012 May; 50(4):1127-32. PubMed ID: 22361454
[TBL] [Abstract][Full Text] [Related]
13. Aromatase inhibitors: structural features and biochemical characterization.
Hong Y; Chen S
Ann N Y Acad Sci; 2006 Nov; 1089():237-51. PubMed ID: 17261771
[TBL] [Abstract][Full Text] [Related]
14. Bicyclic derivatives of the potent dual aromatase-steroid sulfatase inhibitor 2-bromo-4-{[(4-cyanophenyl)(4h-1,2,4-triazol-4-yl)amino]methyl}phenylsulfamate: synthesis, SAR, crystal structure, and in vitro and in vivo activities.
Wood PM; Woo LW; Labrosse JR; Thomas MP; Mahon MF; Chander SK; Purohit A; Reed MJ; Potter BV
ChemMedChem; 2010 Sep; 5(9):1577-93. PubMed ID: 20632362
[TBL] [Abstract][Full Text] [Related]
15. Chiral aromatase and dual aromatase-steroid sulfatase inhibitors from the letrozole template: synthesis, absolute configuration, and in vitro activity.
Wood PM; Woo LW; Labrosse JR; Trusselle MN; Abbate S; Longhi G; Castiglioni E; Lebon F; Purohit A; Reed MJ; Potter BV
J Med Chem; 2008 Jul; 51(14):4226-38. PubMed ID: 18590272
[TBL] [Abstract][Full Text] [Related]
16. Fast three dimensional pharmacophore virtual screening of new potent non-steroid aromatase inhibitors.
Neves MA; Dinis TC; Colombo G; Sá e Melo ML
J Med Chem; 2009 Jan; 52(1):143-50. PubMed ID: 19072235
[TBL] [Abstract][Full Text] [Related]
17. Exploring benzcyclo derivatives as potent aromatase inhibitors using ligand-based modeling studies.
Nagar S; Saha A
Eur J Med Chem; 2010 Sep; 45(9):4307-15. PubMed ID: 20638757
[TBL] [Abstract][Full Text] [Related]
18. Lead optimization of 7-benzyloxy 2-(4'-pyridylmethyl)thio isoflavone aromatase inhibitors.
Su B; Hackett JC; Díaz-Cruz ES; Kim YW; Brueggemeier RW
Bioorg Med Chem; 2005 Dec; 13(23):6571-7. PubMed ID: 16125392
[TBL] [Abstract][Full Text] [Related]
19. Potent aromatase inhibitors and molecular mechanism of inhibitory action.
Kang H; Xiao X; Huang C; Yuan Y; Tang D; Dai X; Zeng X
Eur J Med Chem; 2018 Jan; 143():426-437. PubMed ID: 29202405
[TBL] [Abstract][Full Text] [Related]
20. Aromatase inhibitors: Role in postmenopausal breast cancer.
Kharb R; Haider K; Neha K; Yar MS
Arch Pharm (Weinheim); 2020 Aug; 353(8):e2000081. PubMed ID: 32449548
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]